The importance of biomarkers of post-myocardial infarction heart failure: a systematic review
DOI:
https://doi.org/10.56294/hl2023262Keywords:
Heart failure, cardiac remodeling, biomarkers, post myocardial infarctionAbstract
Heart failure (HF) after a myocardial infarction (MI) is one of the most frequent complications and with the highest mortality rate in the population. Given this, the importance of finding appropriate biomarkers for the diagnosis, prognosis and treatment of this condition. The review was carried out under an analytical approach, using the PRISMA statement as a methodology; for this, documents were retrieved through the Scopus, ScienceDirect and PubMed databases, where 20 articles that met certain inclusion criteria were recognized. In conclusion, it was explained that the use of standard biomarkers such as B-type natriuretic peptide (BNP) and non-terminal pro-BNP in clinical practice have limitations, especially due to their low specificity for HF as a post-MI complication. Therefore, currently, biomarkers that reflect the alteration of cardiac integrity, biomarkers of cardiac injury and necrosis, inflammatory biomarkers, biomarkers of cardiac fibrosis, biomarkers of biomechanical myocardial stress, and other types of biomarkers such as non-coding RNAs are being investigated
References
1. Ralapanawa U, Sivakanesan R. Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review. J Epidemiol Glob Health. 2021;11(2):169. DOI: https://doi.org/10.2991/jegh.k.201217.001
2. Fernando L, Pamela S, Alejandra L. Cardiovascular Disease in Latin America: The Growing Epidemic. Prog Cardiovasc Dis. 2014 Nov;57(3):262–7. DOI: https://doi.org/10.1016/j.pcad.2014.07.007
3. Ministerio de Salud. CARGA DE ENFERMEDAD REGIÓN CAJAMARCA [Internet]. Lima; 2020 Dec. Available from: www.vitalstrategies.org
4. Sequeiros MA, Sebastián G, Zamorano Gómez JL. Complicaciones del infarto agudo de miocardio. Medicine. 2021;13(38):2185–9. DOI: https://doi.org/10.1016/j.med.2021.07.003
5. Zalewski J, Nowak K, Furczynska P, Zalewska M. Complicating Acute Myocardial Infarction. Current Status and Unresolved Targets for Subsequent Research. J Clin Med. 2021 Dec 16;10(24):5904. DOI: https://doi.org/10.3390/jcm10245904
6. Frampton J, Ortengren AR, Zeitler EP. Arrhythmias After Acute Myocardial Infarction. Yale J Biol Med. 2023 Mar 31;96(1):83–94. DOI: https://doi.org/10.59249/LSWK8578
7. Cordero A, Rodríguez-Mañero M, Bertomeu-González V, García-Acuña JM, Baluja A, Agra-Bermejo R, et al. Insuficiencia cardiaca de novo tras un síndrome coronario agudo en pacientes sin insuficiencia cardiaca ni disfunción ventricular izquierda. Rev Esp Cardiol. 2021 Jun;74(6):494–501. DOI: https://doi.org/10.1016/j.recesp.2020.03.020
8. Liang J, Zhang Z. Predictors of in-hospital heart failure in patients with acute anterior wall ST-segment elevation myocardial infarction. Int J Cardiol. 2023 Mar 15;375:104–9. DOI: https://doi.org/10.1016/j.ijcard.2023.01.002
9. Del Buono MG, Moroni F, Montone RA, Azzalini L, Sanna T, Abbate A. Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction. Curr Cardiol Rep. 2022 Oct 16;24(10):1505–15. DOI: https://doi.org/10.1007/s11886-022-01766-6
10. Bahit MC, Kochar A, Granger CB. Post-Myocardial Infarction Heart Failure. JACC Heart Fail. 2018 Mar;6(3):179–86. DOI: https://doi.org/10.1016/j.jchf.2017.09.015
11. Figueiredo R, Adão R, Leite-Moreira AF, Mâncio J, Brás-Silva C. Candidate microRNAs as prognostic biomarkers in heart failure: A systematic review. Revista Portuguesa de Cardiologia. 2022 Oct;41(10):865–85. DOI: https://doi.org/10.1016/j.repc.2021.03.020
12. Macha-Huamán, R., Zavala-Zavala, O. M., Soto, F. C. N., Suárez, J. S. Z., Castañeda, D. R. Y., Lucar, R. G. C., Jibaja, L. C., Mejía, P. J. C., Montoya, C. M. S., Casco, R. J. E., & Romero-Carazas, R. (2023). Business Model Canvas in the entrepreneurs’ business model: a system approach. EAI Endorsed Transactions on Scalable Information Systems, 10(5). https://doi.org/10.4108/eetsis.3594 DOI: https://doi.org/10.4108/eetsis.3594
13. Berezin AE, Berezin AA. Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers. Dis Markers. 2020 Jun 12;2020:1–21. DOI: https://doi.org/10.1155/2020/1215802
14. Leancă SA, Crișu D, Petriș AO, Afrăsânie I, Genes A, Costache AD, et al. Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment. Life. 2022 Jul 24;12(8):1111. DOI: https://doi.org/10.3390/life12081111
15. Piątek-Matuszak P, Pasławski R, Pasławska U, Kiczak L, Płóciennik M, Janiszewski A, et al. Assessment of Myocardial Diastolic Dysfunction as a Result of Myocardial Infarction and Extracellular Matrix Regulation Disorders in the Context of Mesenchymal Stem Cell Therapy. J Clin Med. 2022 Sep 15;11(18):5430. DOI: https://doi.org/10.3390/jcm11185430
16. Humeres C, Frangogiannis NG. Fibroblasts in the Infarcted, Remodeling, and Failing Heart. JACC Basic Transl Sci. 2019 Jun;4(3):449–67. DOI: https://doi.org/10.1016/j.jacbts.2019.02.006
17. Nielsen SH, Mouton AJ, DeLeon-Pennell KY, Genovese F, Karsdal M, Lindsey ML. Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes. Matrix Biology. 2019 Jan;75–76:43–57. DOI: https://doi.org/10.1016/j.matbio.2017.12.001
18. Peng X, Du J, Wang Y. Metabolic signatures in post-myocardial infarction heart failure, including insights into prediction, intervention, and prognosis. Biomedicine & Pharmacotherapy. 2024 Jan;170:116079. DOI: https://doi.org/10.1016/j.biopha.2023.116079
19. Zhan C, Tang T, Wu E, Zhang Y, He M, Wu R, et al. From multi-omics approaches to personalized medicine in myocardial infarction. Front Cardiovasc Med. 2023 Oct 30;10. DOI: https://doi.org/10.3389/fcvm.2023.1250340
20. Almaghrbi H, Giordo R, Pintus G, Zayed H. Non-coding RNAs as biomarkers of myocardial infarction. Clinica Chimica Acta. 2023 Feb;540:117222. DOI: https://doi.org/10.1016/j.cca.2023.117222
21. Sygitowicz G, Maciejak-Jastrzębska A, Sitkiewicz D. MicroRNAs in the development of left ventricular remodeling and post-myocardial infarction heart failure. Pol Arch Intern Med. 2020 Jan 14 DOI: https://doi.org/10.20452/pamw.15137
22. Maries L, Marian C, Sosdean R, Goanta F, Sirbu IO, Anghel A. MicroRNAs—The Heart of Post-Myocardial Infarction Remodeling. Diagnostics. 2021 Sep 13;11(9):1675. DOI: https://doi.org/10.3390/diagnostics11091675
23. Walkowski B, Kleibert M, Majka M, Wojciechowska M. Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart. Cells. 2022 May 5;11(9):1553. DOI: https://doi.org/10.3390/cells11091553
24. Salvatori F, D’Aversa E, Serino ML, Singh AV, Secchiero P, Zauli G, et al. miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach. Int J Mol Sci. 2023 Aug 26;24(17):13268. DOI: https://doi.org/10.3390/ijms241713268
25. Martín-Bórnez M, Falcón D, Morrugares R, Siegfried G, Khatib AM, Rosado JA, et al. New Insights into the Reparative Angiogenesis after Myocardial Infarction. Int J Mol Sci. 2023 Aug 1;24(15):12298. DOI: https://doi.org/10.3390/ijms241512298
26. Dutka M, Bobiński R, Korbecki J. The relevance of microRNA in post-infarction left ventricular remodelling and heart failure. Heart Fail Rev. 2019 Jul 2;24(4):575–86. DOI: https://doi.org/10.1007/s10741-019-09770-9
27. Xiaoqi S, Pingdong C, Yue Z. Infarction or reperfusion-induced cardiac autophagy: role of microRNAs. Journal of Holistic Integrative Pharmacy. 2022;3(4):396–407. DOI: https://doi.org/10.1016/S2707-3688(23)00008-0
28. Yaghoobi A, Rezaee M, Behnoush AH, Khalaji A, Mafi A, Houjaghan AK, et al. Role of long noncoding RNAs in pathological cardiac remodeling after myocardial infarction: An emerging insight into molecular mechanisms and therapeutic potential. Biomedicine & Pharmacotherapy. 2024 Mar;172:116248. DOI: https://doi.org/10.1016/j.biopha.2024.116248
29. Freitas IA de, Lima N de A, Silva Jr GB da, Castro Jr RL de, Patel P, Lima CC de V, et al. Novel biomarkers in the prognosis of patients with atherosclerotic coronary artery disease. Revista Portuguesa de Cardiologia. 2020 Nov;39(11):667–72. DOI: https://doi.org/10.1016/j.repc.2020.05.010
30. Akhtar KH, Khan MS, Baron SJ, Zieroth S, Estep J, Burkhoff D, et al. The spectrum of post-myocardial infarction care: From acute ischemia to heart failure. Prog Cardiovasc Dis. 2024 Jan DOI: https://doi.org/10.1016/j.pcad.2024.01.017
31. Gonzales López, K. M. ., Bernedo-Moreira, D. H. ., Gonzales López, J. N. ., Loayza-Apaza, Y. T. ., Pacompía Quispe, H. F. ., & Papanicolau Denegri, J. N. A. . (2023). Knowledge and attitudes about essential newborn care in women experiencing motherhood for the first time. Salud, Ciencia Y Tecnología - Serie De Conferencias, 2, 380. https://doi.org/10.56294/sctconf2023380 DOI: https://doi.org/10.56294/sctconf2023380
32. Bernedo-Moreira, D. H. ., Papanicolau Denegri, J. N. A., Loayza-Apaza, Y. T. ., Pacompía Quispe, H. F. ., & Gonzales López, J. N. . (2023). Generational diversity and labor productivity, a pressing problem in Peruvian public institutions. Salud, Ciencia Y Tecnología - Serie De Conferencias, 2, 381. https://doi.org/10.56294/sctconf2023381. DOI: https://doi.org/10.56294/sctconf2023381
Downloads
Published
Issue
Section
License
Copyright (c) 2023 César Andrés Vásquez-Donet , Enzo Renatto Bazualdo-Fiorini, Teddy William Saavedra-Alvarado, María Magdalena Portilla-Linares, Jorge Valdez-Portilla, Luis Gonzalo Barrera-Benavides (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
